The Primary
Care Companionfor CNS Disorders

Addiction

Brief Report October 14, 2005

Brief Report: Delirium-Associated Disulfiram and Ethanol Interactions

Hasan Mirsal; Irem Yalug; Devran Tan; Theodore A. Stern; Ayhan Kalyoncu; Ozkan Pektas; Gamze Erdogan; Mansur Beyazyürek

Prim Care Companion J Clin Psychiatry 2005;7(5):235-237

Article Abstract

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Brief Report

Emerging Trends in Opioid Use Disorder Management

April 2, 2024

This report examines trends in opioid use disorder and associated ED visits from 2016 to 2021 and evaluates buprenorphine and naloxone prescribing patterns within these visits.

Abid Rizvi, Christina L. Nolte, Paramjit Chumber, et al

Brief Report

Social Determinants of Health and Extended-Release Naltrexone

June 29, 2023

Patients with alcohol use disorder are at high risk of treatment nonadherence and readmission. While ER naltrexone can help prevent relapse for 28 days, they may face homelessness for...

Lakshit Jain, Vania Modesto-Lowe

Brief Report

An Approach to Address the Need for Adolescent Opioid Stabilization and Treatment

April 18, 2023

This report describes creation and implementation of a protocol to identify and treat opioid use disorder in youth, with the shared goals of providing evidenced-based care in a standardized...

John H. Mahlstedt, Jonathan D. Avery, Megan M. Mroczkowski

Brief Report: Delirium-Associated Disulfiram and Ethanol Interactions

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

Brief Report: Delirium-Associated Disulfiram and Ethanol Interactions

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Emerging Trends in Opioid Use Disorder Management

Social Determinants of Health and Extended-Release Naltrexone

An Approach to Address the Need for Adolescent Opioid Stabilization and Treatment

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles